Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jun;47(6):1221-8.
doi: 10.1016/0031-9384(90)90375-e.

Acute, chronic, and interactive effects of type I and II corticosteroid receptor stimulation on feeding and weight gain

L Devenport  1 , T Thomas, A Knehans, A Sundstrom
Affiliations

Acute, chronic, and interactive effects of type I and II corticosteroid receptor stimulation on feeding and weight gain

L Devenport et al. Physiol Behav. 1990 Jun.

Abstract

Type I (aldosterone) and/or type II (dexamethasone or RU28362) corticosterone receptor agonists were continuously infused in adrenalectomized Sprague-Dawley rats for 28 days at doses of 3.4, 17.2, or 86.2 nmol/day. Additional groups received combined agonist infusions, blank infusions, or sham operations. The type I agonist stimulated body weight gain, and the type II agonists were both suppressive, differing mainly in degree. Although there were a few early effects of these hormones (usually a stage of exaggerated activity), once passed, chronic stimulation was marked by steady or slightly increasing steroid influence on body weight. Throughout the chronic phase of this study there was no departure from a simple opponent model of type I and II ligand actions, and their combination approximated an arithmetic summation of the two separate agonists. This was generally true of feeding as well, although steroid effects on intake were always less pronounced. In contrast to chronic administration, acute combinations of these agonists were highly interactive, producing slight losses than large gains for the aldosterone and RU28362 combinations, but a large gain then small loss for the aldosterone and dexamethasone combination. These results imply that RU28362 and dexamethasone differ in more respects than potency. Because normal endogenous type II stimulation is acute and occurs against a background of type I receptor occupation, mixed agonist interactions are probably the rule for everyday physiological activity, not the exception.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Stress and eating behaviors.
    Yau YH, Potenza MN. Yau YH, et al. Minerva Endocrinol. 2013 Sep;38(3):255-67. Minerva Endocrinol. 2013. PMID: 24126546 Free PMC article. Review.

Publication types

LinkOut - more resources